The best technology decisions are made before choosing the technology

An AI project blocked for months. A data platform reopened for every new use case. A regulatory programme that reveals no one knows which data exists or who is accountable for it.

Up close, they look like different problems. Seen often enough, they are the same: the organisation committed the investment before establishing whether it was ready.

The blockers are rarely in the chosen technology. They sit in unreliable data, rushed integrations, semantics no one governs and responsibilities no one defined.

When a healthcare organisation begins a transformation, the conversation almost always starts in the same place: which platform to use, which vendor to choose, how much it will cost.

Those are legitimate questions. But an earlier one is rarely asked: is this organisation ready for the initiative to succeed?

Failing to ask does not remove the question. It only postpones it until the most expensive moment: once the budget is approved, expectations are set and delivery is under way.

After years of seeing initiatives fail for supposedly different reasons, one constant remains: the data.

Healthcare organisations grow one use case at a time, one integration here, one pipeline there. It works at first. But every new use case forces teams to rebuild logic, mappings and meaning because there is no shared clinical foundation with governed semantics, traceability and reuse built in.

That is why every initiative I assess, AI, EHDS, interoperability or a new platform, is examined through the area where the cause so often lies: the architecture, semantics, governance and traceability of clinical data. It is where my experience lets me see what a general technology assessment misses.

My work answers that question before the decision becomes irreversible: independent assessments grounded in observable evidence, not a consultant's intuition or a vendor presentation.

Independent means exactly that. I do not develop software, implement platforms or represent vendors. My only commitment is to the quality of the decision you need to make.

Sometimes the honest answer is 'not yet'. Finding a readiness gap before signing costs an assessment. Finding it during delivery can cost the project.

Over time, this work is becoming a method: a structured, repeatable and evidence-based way to assess whether a healthcare organisation is ready for technological transformation. Every project adds criteria, patterns and known risks.

Technologies will change. The question will remain the same: are we ready?